Dr. Robert T. Wechsler, MD, PhD

Dr. Wechsler practices at St. Luke's Boise Medical Center in Boise, Idaho, part of St. Luke's Health System.

Dr. Wechsler's NPI, 1962498568, was assigned on September 20, 2005. Dr. Wechsler holds Idaho license M9221.

Dr. Wechsler's primary practice is St. Luke's Boise Medical Center, at 190 East Bannock Street, Boise, ID 83712 in Ada County. The practice phone is (208) 381-2222.

Dr. Wechsler's primary practice is St. Luke's Boise Medical Center in Boise, Idaho, part of St. Luke's Health System. Dr. Wechsler is also affiliated with St. Luke's Nampa Medical Center. Dmand AI also links Dr. Wechsler to 1 more breast imaging center and 1 physician office, each named with a free account. Dr. Wechsler's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wechsler practices, 4 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Wechsler's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Wechsler is licensed in Idaho.

CMS data shows 455 Medicare services from Dr. Wechsler across 8 procedure codes in 2024, for 238 Medicare patients. Medicare paid $31,684 for them.

CMS counts 238 Medicare patients who saw Dr. Wechsler in 2024. The largest group is under 65, with 121 patients. 49% of them have high cholesterol, and 41% have high blood pressure. 51% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wechsler's median patient age at 47, with 56% women.

In 2024, Dr. Wechsler wrote 674 Medicare Part D claims for 124 patients. 61% of them were for generic drugs. CMS names the drug for 569 of them, across 17 drugs with 11 or more claims each, at $596,903 in total drug cost. In 2023, CMS named 534 claims across 18 drugs.

Dr. Wechsler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wechsler as offering telehealth.

Dmand AI links 27 papers to Dr. Wechsler, published from 2014 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Anticonvulsants, Seizures and Double-Blind Method. Dr. Wechsler has published most often in Epilepsia. Dr. Wechsler's most frequent co-authors are Gregory L. Krauss, MD, Sami Mohamad Aboumatar, MD and David Gregg Vossler, MD.

Dmand AI links Dr. Wechsler to 6 clinical trials. Conditions studied include Epilepsy, Attention Deficit Disorder with Hyperactivity and Seizures. Sumitomo Pharma America, Inc. sponsors the most, 4. Open Payments lists research payments to Dr. Wechsler that name 4 trials.

CMS Open Payments shows 1,973 general payments to Dr. Wechsler from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Eisai Inc. paid the most, $381,332. It also lists 23 research payments totaling $46,172 from 2016 to 2019, naming 4 clinical trials.